Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 1
2006 1
2007 4
2008 6
2009 11
2010 21
2011 16
2012 11
2013 10
2014 21
2015 23
2016 25
2017 16
2018 13
2019 38
2020 42
2021 40
2022 29
2023 37
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Results by year

Filters applied: . Clear all
Page 1
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: hattingen e. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.
Franceschi E, Hofer S, Brandes AA, Frappaz D, Kortmann RD, Bromberg J, Dangouloff-Ros V, Boddaert N, Hattingen E, Wiestler B, Clifford SC, Figarella-Branger D, Giangaspero F, Haberler C, Pietsch T, Pajtler KW, Pfister SM, Guzman R, Stummer W, Combs SE, Seidel C, Beier D, McCabe MG, Grotzer M, Laigle-Donadey F, Stücklin ASG, Idbaih A, Preusser M, van den Bent M, Weller M, Hau P. Franceschi E, et al. Among authors: hattingen e. Lancet Oncol. 2019 Dec;20(12):e715-e728. doi: 10.1016/S1470-2045(19)30669-2. Lancet Oncol. 2019. PMID: 31797797 Review.
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
Burger MC, Forster MT, Romanski A, Straßheimer F, Macas J, Zeiner PS, Steidl E, Herkt S, Weber KJ, Schupp J, Lun JH, Strecker MI, Wlotzka K, Cakmak P, Opitz C, George R, Mildenberger IC, Nowakowska P, Zhang C, Röder J, Müller E, Ihrig K, Langen KJ, Rieger MA, Herrmann E, Bonig H, Harter PN, Reiss Y, Hattingen E, Rödel F, Plate KH, Tonn T, Senft C, Steinbach JP, Wels WS. Burger MC, et al. Among authors: hattingen e. Neuro Oncol. 2023 Nov 2;25(11):2058-2071. doi: 10.1093/neuonc/noad087. Neuro Oncol. 2023. PMID: 37148198 Free PMC article.
The neurovasculature as a target in temporal lobe epilepsy.
Reiss Y, Bauer S, David B, Devraj K, Fidan E, Hattingen E, Liebner S, Melzer N, Meuth SG, Rosenow F, Rüber T, Willems LM, Plate KH. Reiss Y, et al. Among authors: hattingen e. Brain Pathol. 2023 Mar;33(2):e13147. doi: 10.1111/bpa.13147. Epub 2023 Jan 4. Brain Pathol. 2023. PMID: 36599709 Free PMC article. Review.
Advances in neuro-oncology imaging.
Langen KJ, Galldiks N, Hattingen E, Shah NJ. Langen KJ, et al. Among authors: hattingen e. Nat Rev Neurol. 2017 May;13(5):279-289. doi: 10.1038/nrneurol.2017.44. Epub 2017 Apr 7. Nat Rev Neurol. 2017. PMID: 28387340 Review.
Neuroradiological and clinical features in ophthalmoplegia.
Weidauer S, Hofmann C, Wagner M, Hattingen E. Weidauer S, et al. Among authors: hattingen e. Neuroradiology. 2019 Apr;61(4):365-387. doi: 10.1007/s00234-019-02183-3. Epub 2019 Feb 12. Neuroradiology. 2019. PMID: 30747268 Review.
Imaging of Amyloid-Related Imaging Abnormalities (ARIA).
Urbach H, Linn J, Hattingen E, Fiebach J. Urbach H, et al. Among authors: hattingen e. Rofo. 2024 Apr;196(4):363-369. doi: 10.1055/a-2185-8472. Epub 2023 Nov 23. Rofo. 2024. PMID: 37995736 English, German.
Multiparametric Quantitative MRI in Neurological Diseases.
Seiler A, Nöth U, Hok P, Reiländer A, Maiworm M, Baudrexel S, Meuth S, Rosenow F, Steinmetz H, Wagner M, Hattingen E, Deichmann R, Gracien RM. Seiler A, et al. Among authors: hattingen e. Front Neurol. 2021 Mar 8;12:640239. doi: 10.3389/fneur.2021.640239. eCollection 2021. Front Neurol. 2021. PMID: 33763021 Free PMC article. Review.
Imaging Characteristics of Meningiomas.
Galldiks N, Hattingen E, Langen KJ, Tonn JC. Galldiks N, et al. Among authors: hattingen e. Adv Exp Med Biol. 2023;1416:21-33. doi: 10.1007/978-3-031-29750-2_3. Adv Exp Med Biol. 2023. PMID: 37432617
308 results